27 OCTOBER 2020
From July-October Njord Medtech has successfully visited and demonstrated core functionality of Atle-prototype-1 at nine Swedish radiology departments.
With the ambition of a robust commercial launch in 2021, Njord Medtech has conducted the first demonstrations outside of the Sahlgrenska University Hospital from July-October. Nine hospitals of different sizes from four different regional councils were given the opportunity to test Atle-prototype-1 in an operational environment.
A qualified majority of the nurses and hospitals confirmed the need and solution area which Atle targets. Valuable feedback was received and Njord is moving forward offering an upcoming test period with seven of the nine hospitals
Njord Medtech® is set on a mission to bring forward new solutions for a value- and a patient-centric healthcare system that contributes to a positive development in society. The company has been incubated within the Sahlgrenska University Hospital since 2017 and incorporated in 2019. Founded by Barbro Cagner - former nurse, union representative, and deputy head at Sahlgrenska Radiology. Njord Medtech continuously strives to solve the unmet needs of patients, caregivers, and doctors to improve the quality of care leveraging an innovation-centric approach.